GOOD
BUSINESS
DELHI-NCR
Nearly 1 in 4 cancer drug prices unchanged: Data

New Delhi: The Centre’s decision to cap trade margins on 137 non-scheduled anti-cancer drugs has reduced the maximum retail prices (MRPs) of 484 of 643 listed medicine packs, but left nearly one in four packs unchanged, raising questions ab
Read the original at Hindustan Times ↗